Prosecution Insights
Last updated: October 04, 2026

Suheung Co. Ltd.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Suheung Co. Ltd. maintains a streamlined prosecution profile in the Biotechnology & Pharmaceuticals technology area. The portfolio presently contains 1 pending office action. This activity is distributed across 1 distinct examiner and 1 distinct art unit, reflecting a point of focus for the company's current legal proceedings at the patent office. This structure implies that the company is not currently managing multiple simultaneous disputes or applications.

HAGOPIAN, CASEY SHEA serves as the busiest examiner for the company, with 1 pending office action under their review. Because the total volume of active cases is limited to 1 pending office action, this examiner is responsible for the entirety of the company's active prosecution. Such a narrow distribution in the Biotechnology & Pharmaceuticals sector suggests that the current workload is limited to a specific technological inquiry. The presence of 1 art unit further confirms that the company's current interests are confined to a specialized field of examination.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HAGOPIAN, CASEY SHEA 1 54.4% +33.3%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18399206 HARD CAPSULE INCLUDING MULTIPLE LOCKING PARTS HAGOPIAN, CASEY SHEA 40d

Top Art Units

Art UnitApps
1617 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18399206 HARD CAPSULE INCLUDING MULTIPLE LOCKING PARTS HAGOPIAN, CASEY SHEA 1617 §103 Non-Final OA 40d Pending Dec 28, 2023

Managing Suheung Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month